Date published: 2026-6-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Delta-4 Activators

Delta-like 4 (Delta-4), a protein encoded by the DLL4 gene, is a crucial component of the Notch signaling pathway, a highly conserved cell signaling system that plays fundamental roles in various developmental processes and tissue homeostasis. Notably, Delta-4 functions as a ligand for Notch receptors, including Notch1 and Notch4, facilitating their activation upon binding. The interaction between Delta-4 and Notch receptors triggers a cascade of intracellular events, ultimately leading to the release of the Notch intracellular domain (NICD) through sequential proteolytic cleavage. Once released, NICD translocates to the nucleus, where it forms a transcriptional activation complex with other co-factors, such as Mastermind-like proteins, and regulates the expression of downstream target genes involved in cell fate determination, differentiation, proliferation, and survival.

Activation of Delta-4 occurs through various mechanisms that predominantly involve post-translational modifications and intracellular trafficking events. One of the primary modes of Delta-4 activation involves glycosylation, a process in which sugar molecules are added to the protein, enhancing its stability and binding affinity to Notch receptors. Additionally, proteolytic cleavage of Delta-4 by specific enzymes, such as Furin, may generate active forms of the protein capable of effectively engaging Notch receptors. Furthermore, intracellular trafficking processes, including endocytosis and exocytosis, contribute to the proper localization and presentation of Delta-4 on the cell surface, ensuring efficient Notch receptor activation. The tight regulation of Delta-4 activation is essential for the precise control of Notch signaling dynamics, which is critical for embryonic development, tissue morphogenesis, and adult tissue homeostasis in multicellular organisms.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

A γ-secretase inhibitor that might indirectly increase DLL4 levels by altering Notch signaling dynamics.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

A histone deacetylase inhibitor that can influence gene expression, potentially affecting DLL4 levels.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Inhibits GSK-3, potentially influencing DLL4 through Wnt/β-catenin signaling pathways.

GSK-3 Inhibitor IX

667463-62-9sc-202634
sc-202634A
sc-202634B
1 mg
10 mg
50 mg
$58.00
$188.00
$884.00
10
(1)

GSK-3 Inhibitor IX (BIO) indirectly affects DLL4 expression by modulating Wnt/β-catenin signaling.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

Inhibits TGF-β signaling, possibly influencing DLL4 expression.

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
$107.00
$156.00
4
(1)

Another TGF-β signaling inhibitor, potentially influencing DLL4 levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, might affect DLL4 expression through cell growth and proliferation pathways.

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$47.00
$143.00
$680.00
16
(1)

An FGFR inhibitor, which might have an indirect impact on DLL4 expression in certain cellular contexts.

SU 5402

215543-92-3sc-204308
sc-204308A
1 mg
5 mg
$63.00
$98.00
36
(3)

A potent FGFR1 inhibitor, potentially affecting DLL4 indirectly